Putnam Investments’s Vir Biotechnology VIR Stock Holding History

Putnam Investments’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$393K	Buy	+39,093	New	+$357K	﹤0.01%	1005
2023 Q3	–	Sell	-76,006	Closed	-$1.86M	–	1212
2023 Q2	$1.86M	Buy	76,006 +1,679	+2%	+$42.2K	﹤0.01%	749
2023 Q1	$1.73M	Sell	74,327 -3,138	-4%	-$80.3K	﹤0.01%	758
2022 Q4	$1.96M	Sell	77,465 -43	-0.1%	-$1.05K	﹤0.01%	724
2022 Q3	$1.49M	Sell	77,508 -1,405	-2%	-$35.7K	﹤0.01%	794
2022 Q2	$2.01M	Sell	78,913 -10,894	-12%	-$254K	﹤0.01%	733
2022 Q1	$2.31M	Buy	89,807 +17,460	+24%	+$518K	﹤0.01%	777
2021 Q4	$3.03M	Buy	+72,347	New	+$2.83M	﹤0.01%	692

Other funds holding VIR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Putnam Investments's VIR Position: Q4 2023 in Review

Putnam Investments opened a new position in Vir Biotechnology (VIR) in Q4 2023: 39,093 shares worth $393K. The stake represents ﹤0.01% of the portfolio and ranks #1005 among its holdings. This is a return to the name: Putnam Investments previously reported a position in VIR as recently as Q2 2023.

Putnam Investments first reported a position in VIR in Q4 2021 and has held it in 8 quarters since. The position peaked at $3.03M in Q4 2021. 206 funds tracked by Wall St. Rank hold VIR as of Q4 2023.

Putnam Investments held 39,093 shares of Vir Biotechnology worth $393K as of Q4 2023.
Vir Biotechnology was a new Putnam Investments position in Q4 2023.
Vir Biotechnology made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1005 holding.
Putnam Investments first reported a position in Vir Biotechnology in Q4 2021 and has held it in 8 quarters since.
Putnam Investments's Vir Biotechnology position peaked at $3.03M in Q4 2021.
206 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.